Cresset
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cresset - overview
Established
2002
Location
-, -, UK
Primary Industry
Software
About
Based in Cambridgeshire, UK, and founded in 2002, Cresset BioMolecular Discovery Limited trading as Cresset operates as a developer of drug discovery and design software that specialized in computer-aided drug discovery (CADD) for the pharmaceutical industries. In September 2022, Scottish Equity Partners invested in Cresset BioMolecular Discovery Limited. As of September 2022, the company is led by its CEO Dr Robert Scoffin. Cresset BioMolecular Discovery Limited solutions include Flare, a platform for ligand-based and structure-based drug design; Blaze, an advanced ligand-based virtual screening, Lead Finder, software equipped with an algorithm and scoring function for virtual screening; PickR; Xed tools; Cresset Engine Broker; Torx; and Spark for pharmaceutical, biotechnology, flavor and fragrance, agrochemical, fine chemicals, and petrochemicals industries.
In addition, the company offers course tutors, principal investigators, postdoctoral researchers, and department heads for both ligand-based and structure-based applications. The company plans to use September 2022, funding to accelerate its product development and expand its presence globally.
Current Investors
Scottish Equity Partners
Primary Industry
Software
Sub Industries
Pharmaceutical Research & Development, Medical Software
Website
www.cresset-group.com
Verticals
Cloud Computing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Cresset - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | molab.ai GmbH | - | ||||||||
| Growth | Completed | Cresset | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.